fig13

Figure 13. (A) The schematic diagram of multimodal diagnosis and treatment of CuS NPs^[177], Copyright © Elsevier B.V. 2020; (B)The schematic representation of the role of CuS-BSA-FA in PDT and PTT^[178], Copyright © Royal Society of Chemisrty 2012; (C) Schematic representation of the preparation of DSF@PEG-HCuSNPs (top) and the corresponding synergistic effects of NIR-II-induced photonic hyperthermia and in situ formation of Cu(DTC)₂ complexes for enhancing the chemotherapeutic efficacy of DSF-based chemotherapy^[179], Copyright © American Chemical Society 2021; (D) The rational design and synthesis of FA-CD@PP-CpG nanocomposites (top), their use in cancer therapy (left), and illustrations of FA-CD@PP-CpG for docetaxel enhanced immunotherapy (right)^[180]; Copyright © Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 2019. BSA: bovine serum albumin ; FA: folic acid; ICG: indocyanine green; NIR: near-infrared region; PDT: photodynamic therapy; PEI: polyethyleneimine; PTT: photothermal therapy.